Ankit has ~15 years of experience in the pharmaceutical and biotechnology industry. He is a finance professional and a strategic leader who has worked on corporate strategy and growth initiatives for diverse businesses. He has a proven track record of executing successful organic and inorganic growth initiatives, optimizing assets, managing risks, and transforming businesses in an evolving environment. He will spearhead strategic growth initiatives, investments, and business transformation at Gland. Before Joining Gland, Ankit was the Vice President of Strategy and Corporate Development for Strides Group, responsible for long-range strategic planning, commercial growth, forecasting, and strategic decision-making for the group's core and emerging businesses. He also worked with the core team on the group's turnaround story in FY23 and was part of several corporate actions. Before Strides, Ankit was part of the consulting leadership team for Christensen (now EY Transaction Advisory), a capital market firm based in Mumbai. He also had a stint with other pharmaceutical companies in API and formulation. Ankit has an MBA in Finance (Gold Medalist) and other certifications in corporate finance, private equity, valuations, business leadership, and strategy.